Ermital (pancreatin) 25000 capsules 25000 IU №20 vial

$41.00

Manufacturer: Germany

Purpose: Pancreatic enzyme replacement for digestive disorders like pancreatitis.

SKU: MED58217 Category:

Description

Ermital (pancreatin) 25000 capsules 25000 IU №20 vial

Ingredients

Ermital capsules contain pancreatin with an activity of 25000 IU.

Dosage

The recommended dosage is as directed by a healthcare professional. Typically, it is advised to take the capsules with meals.

Indications

Ermital capsules are commonly used to aid in the digestion of fats, proteins, and carbohydrates in individuals with pancreatic insufficiency.

Contraindications

Do not take Ermital capsules if you are allergic to any of the ingredients. Consult a healthcare provider before use if pregnant, nursing, or have any underlying medical conditions.

Directions

Swallow the capsules whole with a glass of water. Do not crush or chew them. Follow the dosage instructions provided by your doctor.

Scientific Evidence

Pancreatin, the key ingredient in Ermital capsules, has been extensively studied for its efficacy in aiding digestion. Research published in the “Journal of Clinical Gastroenterology” has shown that pancreatin supplementation can significantly improve fat absorption in individuals with pancreatic insufficiency.

Additional Information

It is important to store Ermital capsules in a cool, dry place away from direct sunlight. Keep the vial tightly closed when not in use to maintain the potency of the medication.

Pharmacological Effects: Pancreatin works by supplementing the digestive enzymes that are lacking in individuals with pancreatic insufficiency. These enzymes help break down fats, proteins, and carbohydrates, aiding in proper digestion and nutrient absorption.

Clinical Trials: Clinical trials have demonstrated the effectiveness of pancreatin supplementation in improving symptoms associated with pancreatic insufficiency, such as bloating, gas, and steatorrhea. Patients have reported improved quality of life and nutritional status with the use of pancreatin.